on a mobile?
 
vTap
    Loading...
 
 
Video
...GlaxoSmithKline Plc, talks with Bloomberg's Nina de Roy and Rishaad Salamat from Middlesex, England, about the safety of diabetes drug Avandia, the outlook for new products and second-quarter ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United Kingdom
Pharmaceutical company
Chief executive officer
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline Plc, talks with Bloomberg's Ellen Braitman from Washington about the safety of the company's Avandia diabetes drug. Glaxo representatives and officials of the U.S. Food and Drug ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
Food and Drug Administration
Chief executive officer
Pharmaceutical company
Go to Feed to see what's new!
share
keep
 
 
GlaxoSmithKline ...Avandia,...Garnier says a buyback programme of that scale is unprecedented in the drug industry. But Reuters editor Mike Dolan says some of that anxiety appears to have eased ...
1m 59s |
a year ago
AOL
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Rosiglitazone
GlaxoSmithKline
A share
United States
Go to Feed to see what's new!
share
keep
 
 
Glaxo appears on TV for the first time since the Avandia safety story broke, with Jean-Pierre Garnier, GlaxoSmithKline CEO & CNBC's Mike Huc...
7m 19s |
a year ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Rosiglitazone
GlaxoSmithKline
CNBC
Go to Feed to see what's new!
share
keep
 
 
GlaxoSmithKline's Q1 profits are down 1%, and Jean-Pierre Garnier, CEO of GlaxoSmithKline, discusses his company's earnings with CNBC's Beck...
4m 42s |
a year ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
CNBC
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Jean-Pierre Garnier, chief executive officer of GlaxoSmithKline Plc, talks with Bloomberg's Francine Lacqua from London about first-quarter earnings, the company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris Pharmaceuticals Inc. Net income fell to 1.31 billion pounds ($2.61 billion), or 24.2 pence a share, as sales of Avandia, once Glaxo's second-best-selling drug, declined 56 percent, the company said today. (Source: Bloomberg)
7 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United States
Chief executive officer
United Kingdom
Pharmaceutical company
Mergers and acquisitions
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums
Privacy Policy and Terms of Use